NEW YORK (TheStreet) -- Auxilium Pharmaceuticals (AUXL) shares are up 42.4% to $30.65 in trading on Wednesday after the company said that it will examine a takeover bid from health care company Endo International (ENDP) .
Endo International is reportedly offering $28.10 per share, valuing the men's health medicines producer at about $2.2 billion, a 31% increase from the stock's closing price yesterday.
Separately, Auxilium said that the proposed bid will not affect its purchase of Canadian drug maker QLT.
Endo International shares are up 3.4% to $67.40 in early market trading today.
- You can view the full analysis from the report here: AUXL Ratings Report
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he and Stephanie Link think could be potentially HUGE winners. Click here to see the holdings for FREE.